Related references
Note: Only part of the references are listed.Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells
Linda Quatrini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
NK cells and ILCs in tumor immunotherapy
Simona Sivori et al.
MOLECULAR ASPECTS OF MEDICINE (2021)
Expanded human NK cells from lung cancer patients sensitize patients' PDL1-negative tumors to PD1-blockade therapy
Sophie M. Poznanski et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
Sophie M. Poznanski et al.
CELL METABOLISM (2021)
The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
Aaron R. Lim et al.
ELIFE (2020)
Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells
Teresa Manzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Jackie E. Bader et al.
MOLECULAR CELL (2020)
Interleukin-15 and cancer: some solved and many unsolved questions
Piera Filomena Fiore et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor
Nicola Tumino et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
Meili Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Martin Felices et al.
JCI INSIGHT (2018)
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Y. Liu et al.
ONCOGENE (2017)
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid
D. Croxatto et al.
ONCOIMMUNOLOGY (2017)
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
Paola Vacca et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
Christiane Sahm et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Relapse-Related Molecular Signature in Lung Adenocarcinomas Identifies Patients With Dismal Prognosis
Shuta Tomida et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)